LSE - Delayed Quote GBp

Oxford Biomedica plc (OXB.L)

Compare
417.00 +1.50 (+0.36%)
At close: November 7 at 6:36 PM GMT
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-28,517.00
-28,517.00
-12,615.00
25,455.00
3,116.00
Investing Cash Flow
2,806.00
2,806.00
-56,462.00
-9,461.00
-10,801.00
Financing Cash Flow
-12,703.00
-12,703.00
98,622.00
46,207.00
38,185.00
End Cash Position
103,716.00
103,716.00
141,285.00
108,944.00
46,743.00
Capital Expenditure
-9,832.00
-9,832.00
-16,296.00
-9,461.00
-13,358.00
Issuance of Capital Stock
651.00
651.00
80,154.00
51,600.00
41,060.00
Issuance of Debt
--
--
64,866.00
--
--
Repayment of Debt
--
--
-31,424.00
--
--
Free Cash Flow
-38,349.00
-38,349.00
-28,911.00
15,994.00
-10,242.00
12/31/2020 - 12/13/1996

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers